High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing

Abstract

Future studies should focus on elucidating genotype specificity and mode-of-action of statins in more detail. This study exemplifies proof of principle of large-scale compound screening in a functional assay using patient-derived organoids.